T. Rowe Price Associates
GOCO

T. Rowe Price Associates’s GoHealth GOCO Stock Holding History

T. Rowe Price Associates’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,400
Closed -$40K – 2951
2022
Q3 		$40K Buy
7,400
+3,047
+70% +$22.9K ﹤0.01% 2861
2022
Q2 		$39K Buy
4,353
+3,578
+462% +$41.6K ﹤0.01% 2884
2022
Q1 		$14K Sell
775
-13,418
-95% -$418K ﹤0.01% 2960
2021
Q4 		$807K Buy
14,193
+1,094
+8% +$73K ﹤0.01% 2135
2021
Q3 		$988K Sell
13,099
-353,752
-96% -$37.4M ﹤0.01% 2067
2021
Q2 		$61.7M Sell
366,851
-13,387
-4% -$2.34M 0.01% 962
2021
Q1 		$66.7M Sell
380,238
-3,129
-0.8% -$631K 0.01% 896
2020
Q4 		$78.6M Sell
383,367
-4,052
-1% -$753K 0.01% 809
2020
Q3 		$75.7M Buy
+387,419
New +$93.3M 0.01% 737

Other funds holding GOCO

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates's GOCO Position: Q4 2022 in Review

T. Rowe Price Associates sold out of GoHealth (GOCO) in Q4 2022, closing a stake of 7,400 shares — an estimated $40K sold.

T. Rowe Price Associates first reported a position in GOCO in Q3 2020 and held it in 9 quarters. The position peaked at $78.6M in Q4 2020. 35 funds tracked by Wall St. Rank hold GOCO as of Q4 2022.

  • T. Rowe Price Associates reported no remaining GoHealth position as of Q4 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 7,400 GoHealth shares in Q4 2022, an estimated $40K.
  • T. Rowe Price Associates first reported a position in GoHealth in Q3 2020 and held it in 9 quarters.
  • T. Rowe Price Associates's GoHealth position peaked at $78.6M in Q4 2020.
  • 35 funds tracked by Wall St. Rank held GoHealth as of Q4 2022.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.